Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026

Novelix Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
32.1529.596.791.182.7528.9
Short-Term Investments
---2525-
Trading Asset Securities
---8.733.911.19
Cash & Short-Term Investments
32.1529.596.7934.9131.6630.09
Cash Growth
121.67%335.99%-80.56%10.26%5.22%29.25%
Accounts Receivable
1,057589.62181.370.131.912.32
Other Receivables
-22.941.582.833.663.89
Receivables
1,144710.86253.182.976.3420.38
Inventory
152.71144.328.433.214.298.77
Prepaid Expenses
--0.180.010.130.08
Other Current Assets
27.924.350.750.2--0
Total Current Assets
1,356889.11269.3341.342.4359.31
Property, Plant & Equipment
31.4815.221.861.181.744.55
Long-Term Investments
0.430.430.4330.6427.754.22
Other Intangible Assets
40.419.2-000.11
Long-Term Deferred Tax Assets
4.370.270.450.540.650.66
Other Long-Term Assets
--00--18.54
Total Assets
1,433924.23272.0773.6572.5787.38

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
693.01402.5492.010.030.548.83
Accrued Expenses
-5.293.360.070.070.09
Current Portion of Long-Term Debt
-----0.34
Current Income Taxes Payable
-8.30.3---
Other Current Liabilities
21.4343.22100.010.05
Total Current Liabilities
714.43459.3596.670.10.629.29
Long-Term Debt
65.26----1.31
Total Liabilities
779.7459.3596.670.10.6210.6

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
284.7210.8599.5818181
Additional Paid-In Capital
-247.2394.6512.1512.1512.15
Retained Earnings
-6.81-18.76-19.6-24.32-22.74
Comprehensive Income & Other
368.78---3.123.63
Total Common Equity
653.48464.88175.3973.5571.9574.04
Minority Interest
-----2.74
Shareholders' Equity
653.48464.88175.3973.5571.9576.78
Total Liabilities & Equity
1,433924.23272.0773.6572.5787.38

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
65.26----1.65
Net Cash (Debt)
-33.1229.596.7934.9131.6628.44
Net Cash Growth
-335.99%-80.56%10.26%11.31%22.18%
Net Cash Per Share
-1.181.400.683.353.913.51
Filing Date Shares Outstanding
27.4228.479.958.18.18.1
Total Common Shares Outstanding
27.4221.099.958.18.18.1
Working Capital
642.06429.76172.6641.241.8150.02
Book Value Per Share
23.8322.0517.639.088.889.14
Tangible Book Value
613.08445.68175.3973.5571.9573.93
Tangible Book Value Per Share
22.3621.1417.639.088.889.13
Buildings
-1.431.431.431.431.43
Machinery
-27.2512.9111.8512.0414.54